I-MED PHARMA TO LAUNCH ITS MOST ADVANCED ARTIFICIAL TEAR TO DATE WITH I-DROP® MGD
MONTREAL, February 03, 2020 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
Montreal, June 17, 2019 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
I-LID ’N LASH®, I-LID ’N LASH® PLUS & I-PEN® NOW AVAILABLE IN SWITZERLAND THROUGH PARTNERSHIP WITH PROLENS AG
MONTREAL, May 28, 2019 I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis…
I-MED Pharma Becomes the Authorized Canadian Distributor for the OrCam MyEye 2
MONTREAL, April 10, 2019 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in…
I-MED Pharma Celebrates 30 Years of Providing OSD & Surgical Solutions to the Global Eye Care Community
MONTREAL, April 1, 2019 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
I-PEN® Osmolarity System Now Available in Brazil Through Partnership with DryCom
MONTREAL, March 26, 2019 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in…
I-MED Pharma Partners with Iogen Oy to Introduce I-DROP®, I-LID ’N LASH®, I-RELIEFTM Therapeutic Eye Mask and the I-PEN® Osmolarity System to the Finnish Market.
MONTREAL, November 1st, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the U.S Market.
I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the…
I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg & the Netherlands
I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg &…
Quebec Government Supports I-MED Pharma by Helping Fund International Expansion
West Island businesses get financial boost from Quebec Government The Quebec government is giving several…
I-MED Pharma Inc. Announces Partnership with Medicals International
MONTREAL, July 23, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada
Montreal, May 24, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in…
I-MED Pharma’s I-PEN® Receives Regulatory Approval from INVIMA in Colombia and ANMAT in Argentina
Montreal, April 3, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian Company specializing in…
I-MED Pharma’s I-PEN® Does Not Infringe the TearLab Patent
Montreal, February 20, 2018 (GLOBE NEWSWIRE) – On February 14th TearLab issued a press release…
I-MED Pharma Wins Patent Case Against TearLab
Montreal, February 13, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., announced today that TearLab’s efforts…
I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.
Montreal, January 8, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in…
I-PEN®and I-PLUG® now available in Spain and Portugal through Partnership with IMEX
MONTREAL, January 8, 2018 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in…
